News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
FDA Spurns Vertex (VRTX) Application for Expanded Use of Kalydeco     2/5/2016
How Vertex (VRTX)'s Long-Term $500K Gamble Paid Off with a $30 Billion Return     11/18/2015
Vertex (VRTX)'s Success Spurs Startups Corbus and Pulmatrix to Enter Cystic Fibrosis Market     8/18/2015
Watch Out Gilead (GILD), Investors Feel Vertex (VRTX) May Be Biogen (BIIB)'s Good Fit     8/4/2015
Vertex (VRTX) Gets FDA Approval for $259K Per Year CF Drug     7/7/2015
Vertex (VRTX) Poised to Become Profitable Following Expected FDA Approval of Orkambi     7/1/2015
Tiny Parion Sciences Wrangles Lung Pact Worth $1.2 Billion From Vertex (VRTX)     6/8/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/29/2015
Your Analyst-Vetted Guide to the Five Blockbuster Drugs the FDA May Approve This Summer     5/28/2015
Vertex (VRTX) Soars After Hours as FDA Panel Backs Cystic Fibrosis Drug Orkambi     5/15/2015
Investors Hold Their Breath as Vertex (VRTX) Defends Newly Branded Cystic Fibrosis Treatment to the FDA     5/12/2015
Heart-Stopping Morning Leads to Vertex (VRTX) Rise As FDA News Sees Positives     5/11/2015
Tiny Corbus Looks to Give Vertex (VRTX) Some Competition With Experimental Cystic Fibrosis Drug     5/6/2015
Buy Vertex (VRTX) Now for $45B Or Risk It All, Analyst Tells Gilead (GILD)     4/27/2015
Here's Why Investors are Already Anticipating Vertex (VRTX) Trial Data Coming This Month     3/17/2015

News from Around the Web
The Importance Of Implementing CF Newborn Screening Reinforced, McGill University Study     5/5/2016
Researchers Build Promising CF Diagnostic System Using Microsoft's Xbox Kinect Sensors     3/30/2016
Fast, Accurate Cystic Fibrosis Test Developed At Stanford University     2/2/2016
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Garlic Could Help Cure Lung Infection, University of Edinburgh Study     2/25/2015
University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn’t Affect Lungs     7/23/2014
Cystic Fibrosis And Diabetes Link Explained, Lund University Study     6/3/2014
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012
Student, 16, Invents New Drug Cocktail to Fight Cystic Fibrosis, Wins Canadian Biotech Challenge, National Research Council of Canada laboratories Reveals     5/12/2011
Cystic Fibrosis Patients May Benefit From Combination Therapy Which Provides Hope For Cure Of Dangerous Infections, McMaster University Study     4/25/2011
New Cystic Fibrosis Drug Improves Lung Function, University of Colorado Study     12/22/2010
Novel Drug Aids CF Kids' Lungs, University of Colorado Study     12/20/2010

Press Releases
Health Canada Authorizes ProMetic Life Sci (PFSCF.PK) To Proceed With Its PBI-4050 Clinical Trial In Patients With Cystic Fibrosis     5/18/2016
Nivalis Therapeutics Announces First Patient Dosed In Second Phase II Study Of N91115 For Treatment Of Cystic Fibrosis     5/17/2016
Galapagos (GLPG.BR) Starts Phase 1 Study With Potentiator GLPG2451 For CF     5/10/2016
Acetylon Pharmaceuticals Publishes New Mechanism For The Treatment Of Sickle Cell Disease/Beta-Thalassemia With Selective HDAC1/2 Inhibition In Plos One     5/4/2016
Concert Pharmaceuticals, Inc. (CNCE) Announces Positive Data From Multiple Dose Phase 1 Clinical Trial Of CTP-656, Lead Candidate For The Treatment Of Cystic Fibrosis     4/29/2016
AmpliPhi Biosciences Corporation (APHB) Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients     4/13/2016
TGV-inhalonix Receives Orphan Drug Status For Its Novel Antibiotic To Treat Resistant Infections In Cystic Fibrosis     4/13/2016
Proteostasis (PTI) Presents New Data Demonstrating Potential For Genotype-Agnostic And Combination Therapies For People With Cystic Fibrosis     4/1/2016
Sandoz Canada Launches Prtobramycin INHALATION SOLUTION, A Generic Version Of Prtobi Indicated For Pulmonary Infections In Cystic Fibrosis Patients     3/31/2016
Pulmatrix Reports 2015 Financial Results; Provides 2016 Outlook On Pulmonary Disease Pipeline     3/10/2016
RespirTech Develops Novel Remote Monitoring System For Cystic Fibrosis Patients As Part Of SBIR Grant     3/10/2016
Vertex (VRTX) Receives Australian Approval For ORKAMBI (Lumacaftor/Ivacaftor), The First Medicine To Treat The Underlying Cause Of Cystic Fibrosis In People Ages 12 And Older With Two Copies Of The F508del Mutation     3/9/2016
Concert Pharmaceuticals, Inc. (CNCE) Announces CTP-656 Solid Dose Phase 1 Results Confirmed Superior Pharmacokinetic Profile To Kalydeco     3/1/2016
Savara Completes $20 Million Round Of Financing     3/1/2016
Senator Orrin Hatch Receives “Legislative Champion Award” From Cystic Fibrosis Foundation For Breaking Down Barriers To Clinical Trial Participation     2/25/2016